2018-05-14T15:33:34-05:00 2017-06-30 ERNST & YOUNG US LLP 2100 ONE PPG PLACE PITTSBURGH PA 15222 990 2016-07-01 900593925 THE SUBSIDIARIES OF THE INSTITUTE FOR TRANSFUSION MEDICINE % CHARLES LACLAIR SUBS 4122097300 875 GREENTREE RD PC5 PITTSBURGH PA 15220 TANYA PERRY CFO 4806755503 2018-05-14 2016 2022-09-23 18:48:47Z TANYA PERRY 6210 E OAK STREET SCOTTSDALE AZ 85257 207869834 true true 5645 X www.itxm.org X PA TO PROVIDE BEST IN CLASS BLOOD PRODUCTS AND CLINICAL SERVICES TO MEET THE NEEDS OF THE HEALTHCARE COMMUNITY, PATIENTS & OUR DONORS THROUGH ADVANCED TRANSFUSION MEDICINE PRACTICES. 52 45 1270 155 25000 24000 584869 543260 191016919 204815206 6418676 1592559 1095155 816867 199115619 207767892 4039429 1595404 0 0 65855027 66961837 0 0 0 127217031 141190627 197111487 209747868 2004132 -1979976 286020449 196448214 18093534 21994339 267926915 174453875 X ITXM'S MISSION IS TO PROVIDE BEST IN CLASS BLOOD PRODUCTS AND CLINICAL SERVICES TO MEET THE NEEDS OF THE HEALTHCARE COMMUNITY, PATIENTS AND OUR DONORS THROUGH ADVANCED TRANSFUSION MEDICINE PRACTICES. ITXM'S VISION IS TO BE THE PREMIER PROVIDER OF BLOOD TRANSFUSION PRACTICES BY DELIVERING INNOVATIVE INDUSTRY LEADING SOLUTIONS THAT ENSURE THE HIGHEST QUALITY PRODUCTS AND SERVICES, OPERATING EFFICIENCIES, DONOR SATISFACTION AND IMPROVED PATIENT CARE RESULTING IN THE ACHIEVEMENT OF OUR MISSION. ITXM'S MISSION AND VISION ARE SUPPORTED BY OUR VALUES OF STEWARDSHIP, INTEGRITY, ACCOUNTABILITY, RESPECT, EXCELLENCE AND INNOVATION. false true 105319955 0 104606952 THE PRIMARY PURPOSE OF CENTRAL BLOOD BANK, LIFESOURCE AND VIRGINIA BLOOD SERVICES IS TO PROMOTE PUBLIC PARTICIPATION IN A COMMUNITY-BASED BLOOD PROGRAM. A SUCCESSFUL BLOOD PROGRAM HELPS TO ASSURE AN ADEQUATE AND SAFE BLOOD SUPPLY TO THOSE MEMBERS OF THE COMMUNITY IN NEED. IN ADDITION TO HUMAN BLOOD COLLECTIONS, THE BLOOD BANKS ARE ACTIVELY INVOLVED WITH BONE MARROW AND APHERESIS TISSUE COLLECTIONS. DONOR COUNSELING IS ALSO AN IMPORTANT SERVICE PROVIDED TO THE DONATING PUBLIC. 33924952 0 42761303 CLINICAL SERVICES PROVIDES BLOOD AND BLOOD-RELATED DIAGNOSTIC TESTS AND PROCEDURES TO ENSURE THAT THE UNITS OF DONATED BLOOD ARE COMPATIBLE WITH SPECIFIC PATIENTS. CLINICAL SERVICES ALSO OPERATES THE ONLY PUBLIC CORD BLOOD BANK IN THE CHICAGO AREA. ITXM DIAGNOSTICS PROVIDES TESTING SERVICES AND UNDERTAKES RESEARCH AND EDUCATIONAL ACTIVITIES WITH RESPECT TO BLEEDING AND CLOTTING DISORDERS AND PROVIDES THERAPEUTIC APHERESIS SERVICES. 47492367 1595404 58197053 THE HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA PROVIDES MEDICAL SERVICES TO PERSONS WITH CONGENITAL BLEEDING AND CLOTTING DISORDERS AND WORKS TO DEVELOP AND SUPPORT EDUCATIONAL, RESEARCH AND THERAPEUTIC SERVICES. THEY OPERATE A 340B DRUG DISTRIBUTION PROGRAM WHICH PROVIDES FUNDS TO SUPPORT PERSONNEL, PERFORM OUTREACH CLINICS, ENHANCE COMMUNICATION VIA WEB SITE AND BROCHURES, IMPROVE BUSINESS OPERATIONS AND CLINICAL CARE THROUGH THE IMPLEMENTAION OF ELECTRONIC MEDICAL RECORDS, SUPPORT OTHER 501(C)(3) ORGANIZATIONS THAT PROVIDE EDUCATION AND CAMP OPPORTUNITIES FOR PATIENTS. 186737274 true true false true false false false false false false true true false false true true false true false false true false false false false false false true false true false false false false false false false false true false false false false true true false false false true 99 0 true 1270 true true true false false false false false false false false false X 52 45 false false false false true true true true true false false true true true true true true true true false IL PA VA X CHARLES LACLAIR 4122097385 5 PARKWAY CENTER 875 GREENTREE ROAD PITTSBURGH PA 15220 X JAMES P COVERT CBB,PRES & CEO (THRU 2/17) 1.0 39.0 X X 0 614575 241787 MARK J GIAQUINTO CBB SECY/TREAS (THRU 2/17) 1.0 39.0 X X 0 311510 115275 DIANE MERKT CBB VP (THRU 4/17) 1.0 39.0 X X 0 256432 96599 LINDA HAHN CLINICAL SVCS OFFICR(THRU2/17) 40.0 0.0 X X 248350 0 146977 ANDREA CORTESE HASSETT PHD ITXM DIAG OFFICER (THRU 2/17) 39.0 1.0 X X 205091 0 154171 FRANKLIN BONTEMPO MD ITXM DIAG DIRECTOR (THRU 2/17) 40.0 0.0 X 120674 0 19178 MARGARET V RAGNI MD HCWP DIRECTOR 40.0 0.0 X 0 0 0 A KIM RITCHEY MD HCWP DIRECTOR 1.0 0.0 X 0 0 0 DARRELL TRIULZI MD HCWP DIRECTOR 1.0 0.0 X 0 0 0 EDWARD CHU MD HCWP CHAIR 1.0 0.0 X X 0 0 0 MARK GLADWIN MD HCWP DIRECTOR 1.0 0.0 X 0 0 0 JAMES P COVERT LS PRES & CEO (THRU 2/17) 1.0 39.0 X X 0 0 0 JAMES P COVERT CLIN SVCS PRES&CEO (THRU 2/17) 1.0 39.0 X X 0 0 0 JAMES P COVERT ITXM DIAG PRES&CEO (THRU 2/17) 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO LS SECY/TREAS (THRU 2/17) 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO CLIN SVC SECY/TREAS(THRU 2/17) 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO DIAG SECY/TREAS (THRU 2/17) 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO HCWP DIRECTOR & SECY/TREAS 1.0 39.0 X X 0 0 0 DIANE MERKT LIFESOURCE VP (THRU 4/17) 1.0 39.0 X X 0 0 0 DIANE MERKT HCWP DIRECTOR (THRU 4/17) 1.0 39.0 X 0 0 0 JAMES P COVERT VBS PRES & CEO (THRU 2/17) 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO VBS SECY\TREAS (THRU 2/17) 1.0 39.0 X X 0 0 0 DIANE MERKT VBS VP (THRU 4/17) 1.0 39.0 X X 0 0 0 ANDREA CORTESE HASSETT PHD HCWP DIRECTOR 1.0 39.0 X 0 0 0 PATRICIA ABREGO-SANTUCCI VICE-CHAIR (EFF 3/17) 1.0 1.0 X X 0 13500 0 SUNNY CHICO DIRECTOR (EFF 3/17) 1.0 1.0 X 0 9250 0 ROBERT COLE CHAIR (EFF 3/17) 1.0 1.0 X X 0 21500 0 J DANIEL CONNOR DIRECTOR (3/17 THRU 5/17) 1.0 1.0 X 0 834094 40083 MICHAEL JONES DIRECTOR (EFF 3/17) 1.0 1.0 X 0 12750 0 JOHN LEWIS DIRECTOR (EFF 3/17) 1.0 1.0 X 0 47250 0 RICHARD MCHUGH MD DIRECTOR (EFF 3/17) 1.0 1.0 X 0 13500 0 JAMES SCHRAITH DIRECTOR (EFF 3/17) 1.0 1.0 X 0 21500 0 PAUL STANDER MD SECY/TREAS (EFF 3/17) 1.0 1.0 X X 0 17500 0 DAVID GREEN DIRECTOR (EFF 5/17) 1.0 39.0 X 0 514557 31561 JAMES P COVERT HCWP CEO (THRU 2/17) 1.0 39.0 X 0 0 0 SUSAN BARNES CFO (EFF 3/17) 1.0 39.0 X 0 439625 22214 BHAVI SHAH GEN COUNSL/ASST SEC (EFF 3/17) 1.0 39.0 X 0 312570 25367 CHARLES WILCOX III INTERIM DIV PRES (EFF 3/17) 30.0 10.0 X 0 276878 21375 MONA PAPARI LIFESOURCE MEDICAL DIRECTOR 40.0 0.0 X 243811 0 23659 MICHELE TYSARCZYK CENTRAL BLOOD BANK EXEC DIR 40.0 0.0 X 168237 0 69327 CHELSEA SHEPPARD MD VIRGINIA BLOOD SVCS MED DIR 40.0 0.0 X 200594 0 11236 JASON CRANE LS ASSOCIATE MEDICAL DIRECTOR 40.0 0.0 X 176103 0 44577 TODD CAHILL REGIONAL EXECUTIVE DIRECTOR 40.0 0.0 X 199918 0 20148 1562778 3716991 1083534 31 false true false INCEPT CORPORATION 4150 BELDEN VILLAGE ST NW SUITE 2 CANTON OH 44718 TELERECRUITMENT SVCS 1202157 CREATIVE TESTING SOLUTIONS PO BOX 29871 PHOENIX AZ 85038 DONOR TESTING 12410850 AIT WORLDWIDE LOGISTICS INC PO BOX 66730 CHICAGO IL 60666 SHIPPING 833125 AMERICAN EXPEDITING COMPANY INC 801 NORTH PRIMOS AVENUE FOLCROFT PA 19032 SHIPPING 1371751 SUMMITT FACILITIES MANAGEMENT 2241 HILLWOOD COURT LIZELLA GA 31052 FACILITIES MGMT SVCS 1026706 17 429 100501 269638 172692 145432 543260 BLOOD PRODUCTS & COMPONENTS 900099 97135027 97135027 FACTOR PROGRAM REVENUE 621400 58147993 58147993 BLOOD & BLOOD RELATED TESTING 900099 49532186 49532186 204815206 1581152 1581152 0 0 90998 49233 41765 0 41765 41765 64116 52709 11407 11407 11407 0 0 0 0 0 0 0 0 0 REVENUE FROM AFFILIATED ORGANIZATIONS 900099 604223 604223 REVENUE FROM RESEARCH 900099 139423 139423 ADVERTISING INCOME 900099 25000 25000 6456 6456 775102 207767892 205565308 25000 1634324 1595404 1595404 0 0 0 574115 120674 453441 0 0 50940790 50940790 3788704 3788704 8032871 8032871 3625357 3625357 158079 158079 1015 1015 4208 4208 98373 98373 0 92642 92642 3196681 3196681 0 0 1401340 1401340 7285689 7285689 1119921 1119921 0 6193959 6193959 2101064 2101064 0 22090 22090 4541 4541 0 5866845 5866845 417471 417471 FACTOR PROGRAM EXPENSES 42751065 42751065 0 0 TESTING & LABORATORY SUPPLIES 33292985 33292985 0 0 ITXM SHARED SERVICES 22306432 0 22306432 0 BLOOD PRODUCTS & COMPONENTS 11268679 11268679 0 0 3607548 3607548 209747868 186737274 23010594 0 251593 166694 0 0 51574 40612 20978798 18874875 0 0 0 0 0 0 6686038 8157572 926941 765685 118051544 56676057 63570921 61375487 0 0 182574413 99023265 0 0 127994 109998 10852177 7934026 286020449 196448214 16615000 16467015 1196786 721502 281748 308468 0 0 0 0 0 0 0 0 0 0 0 4497354 18093534 21994339 X 204385915 104421875 63541000 70032000 0 0 267926915 174453875 286020449 196448214 X -1979976 8913032 -100406096 X false true X true true true X 325632 458039 448649 584869 543260 2360449 159552851 202368028 194701254 191016919 204815206 952454258 0 0 0 0 0 0 0 0 0 0 0 0 0 159878483 202826067 195149903 191601788 205358466 954814707 0 0 0 0 0 0 112635772 97989926 106983323 104964575 84996384 507569980 112635772 97989926 106983323 104964575 84996384 507569980 447244727 2460958 2770341 1935564 6496025 1672150 15335038 0 0 0 25000 25000 50000 2460958 2770341 1935564 6521025 1697150 15385038 0 800431 1183298 1074384 1013614 750102 4821829 163139872 206779706 198159851 199136427 207805718 975021574 0.45870 0.41499 0.01578 0.01601 X false false false false false 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SCHEDULE A, PART III THE IRS EO BUSINESS MASTER FILE ERRONEOUSLY LISTS EACH OF THE ORGANIZATIONS INCLUDED IN THIS RETURN AS A SECTION 509(A)(3) SUPPORTING ORGANIZATION. HOWEVER, ALL ORGANIZATIONS INCLUDED IN THE RETURN ARE EITHER SECTION 509(A)(1) OR 509(A)(2) ORGANIZATIONS. APPROPRIATELY, SCHEDULE A, PART III HAS BEEN COMPLETED FOR THE SECTION 509(A)(2) ORGANIZATIONS, AND SCHEDULE A, PART IV HAS NOT BEEN COMPLETED. SCHEDULE A, PART III, LINE 12 THE AMOUNT ON LINE 12 DOES NOT INCLUDE CAPITAL GAINS IN THE AMOUNT OF: 2012 $337,871 2013 $6,461 2014 $(592) 2015 $23,178 2016 $11,407 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false true 98373 false false 98373 false SCHEDULE C, PART II-B, LINE 1G A CONSULTANT IS COMPENSATED TO ACT AS THE EXECUTIVE DIRECTOR AND LEGISLATIVE COORDINATOR FOR THE ILLINOIS COALITION OF COMMUNITY BLOOD CENTERS. THE CONSULTANT RESEARCHES DONOR TRENDS AND WAYS TO IMPROVE BLOOD DONATIONS AND ACTS AS AN ADVOCATE FOR THE SUCCESSFUL PASSAGE OF LEGISLATION THAT WILL HELP INCREASE BLOOD DONATIONS. A LEGAL FIRM IS RETAINED FOR REPRESENTATION ON MATTERS AFFECTING PUBLIC POLICY WHICH INVOLVES LOBBYING CONGRESS TO RECOMMEND TO HRSA TO GRANT AN EXCEPTION ON THE USE OF 340B FUNDS FOR A RELATED, BUT DIFFERENT, COMMUNITY HEALTH CAUSE. 704950 6592304 7297254 4962278 57668058 21003722 41626614 6452987 4015792 2437195 27469515 20479164 6990351 14201452 11177379 3024073 61375487 FIXED INCOME FUNDS 20750005 F EQUITY FUNDS 65308879 F SHORT-TERM INVESTMENTS 57122 F ALTERNATIVE INVESTMENTS 12907259 F 99023265 0 PAYABLE TO BSI 4497354 4497354 X SCHEDULE D PART X, LINE 2 THE SUBSIDIARIES OF THE INSTITUTE FOR TRANSFUSION MEDICINE RECEIVED A CONSOLIDATED AUDITED FINANCIAL STATEMENT FOR THE TAX YEAR ENDING FEBRUARY 28, 2017 THAT WAS PREPARED IN ACCORDANCE WITH GAAP. A FIN 48 FOOTNOTE TO THE AUDITED FINANCIAL STATEMENTS DISCLOSED "ITXM'S CONSOLIDATED BALANCE SHEET DOES NOT INCLUDE ANY LIABILITIES ASSOCIATED WITH UNCERTAIN TAX POSITIONS; FURTHER, ITXM HAS NO UNRECOGNIZED TAX BENEFITS." Central America and the Caribbean Investments 8824082 Europe (Including Iceland and Greenland) Investments 4083177 12907259 12907259 false false true false false false true UNIVERSITY OF PITTSBURGH-DEPT OF MEDICINE 1218 SCAIFE HALL PITTSBURGH PA 15261 250965591 501(C)(3) 1375000 ESTABLISH A HEMOSTASIS AND VASCULAR BIOLOGY INSTITUTE TO FURTHER BASIC AND CLINIC RESEARCH AND EDUCATION REGARDING BLOOD DISEASES WESTERN PA CHAPTER OF THE HEMOPHILIA FDN 20411 RT 19 UNIT 14 CRANBERRY PA 16066 251359331 501(C)(3) 125000 TO IMPROVE THE LIVES OF THE MEMBERS OF THE BLEEDING DISORDERS COMMUNITY THROUGH EDUCATIONAL PROGRAMS, GUIDANCE AND SUPPORT. FDN FOR WOMEN & GIRLS WITH BLEEDING DISORDERS 11 CLOVERHILL PLACE MONTCLAIR NJ 04042 272456813 501(C)(3) 75000 ENSURE WOMEN AND ADOLESCENT GIRLS WITH BLOOD DISORDERS ARE CORRECTLY DIAGNOSED AND OPTIMALLY TREATED AND MANAGED AT EVERY LIFE STAGE. CHILDREN'S HOSPITAL OF PHILADELPHIA 3501 CIVIC CENTER BLVD PHILA PA 19104 231352166 501(C)(3) 20404 SUPPORT THE ANNUAL EDUCATIONAL MEETING FOR FEDERALLY FUNDED HEMOPHILIA TREATMENT CENTERS. 4 PART I LINE 2 - HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA AS PART OF ITS ANNUAL BUDGET PROCESS, THE HEMOPHILIA CENTER DETERMINES APPROPRIATE LEVELS OF COMMUNITY SUPPORT BASED ON REQUESTS RECEIVED BY 501(C)(3) ORGANIZATIONS WHO SHARE SIMILAR MISSIONS IN SERVICING THE NEEDS OF THE BLEEDING DISORDERS COMMUNITY. THE CENTER REVIEWS ALL REQUESTS ALONG WITH PRIOR FUNDING REPORTS FROM THE ORGANIZATIONS WHICH ARE PRESENTED TO THE CENTER PRESIDENT/MEDICAL DIRECTOR AND EXECUTIVE DIRECTOR AND THEN SUBSEQUENTLY VOTED ON BY THE BOARD DURING THE ADOPTION OF THE ANNUAL BUDGET. EACH FUNDING REQUEST REQUIRES THE RECIPIENT ORGANIZATION TO SIGN A FINANCIAL ASSISTANCE AGREEMENT WHICH STIPULATES THE DURATION OF THE FUNDING, THE AMOUNT OF THE FUNDING, THE INTENDED USE OF THE FUNDS, AND REQUIRES AN ACCOUNTING OF THE UTILIZED FUNDS. ALL RESEARCH GRANT FUNDING PROVIDED BY THE HEMOPHILIA CENTER MUST BE APPROVED BY THE HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA). X true true false true false false false false false false false JAMES P COVERT CBB,PRES & CEO (THRU 2/17) 0 473212 0 141363 0 0 0 213255 0 28532 0 856362 0 0 MARK J GIAQUINTO CBB SECY/TREAS (THRU 2/17) 0 280358 0 31152 0 0 0 92582 0 22693 0 426785 0 0 DIANE MERKT CBB VP (THRU 4/17) 0 230316 0 26116 0 0 0 86996 0 9603 0 353031 0 0 LINDA HAHN CLINICAL SVCS OFFICR(THRU2/17) 203960 0 16372 0 28018 0 125693 0 21284 0 395327 0 0 0 ANDREA CORTESE HASSETT PHD ITXM DIAG OFFICER (THRU 2/17) 187924 0 17167 0 0 0 129661 0 24510 0 359262 0 0 0 MONA PAPARI LIFESOURCE MEDICAL DIRECTOR 243811 0 0 0 0 22451 0 1208 0 267470 0 0 0 MICHELE TYSARCZYK CENTRAL BLOOD BANK EXEC DIR 151780 0 8505 0 7952 0 46785 0 22542 0 237564 0 0 0 CHELSEA SHEPPARD MD VIRGINIA BLOOD SVCS MED DIR 200594 0 0 0 0 0 8012 0 3224 0 211830 0 0 0 JASON CRANE LS ASSOCIATE MEDICAL DIRECTOR 176103 0 0 0 0 0 16154 0 28423 0 220680 0 0 0 TODD CAHILL REGIONAL EXECUTIVE DIRECTOR 167720 0 32198 0 0 0 0 0 20148 0 220066 0 0 0 J DANIEL CONNOR DIRECTOR (3/17 THRU 5/17) 0 699339 0 123505 0 11250 0 28600 0 11483 0 874177 0 0 SUSAN BARNES CFO (EFF 3/17) 0 344201 0 56235 0 39189 0 10600 0 11614 0 461839 0 28901 BHAVI SHAH GEN COUNSL/ASST SEC (EFF 3/17) 0 261118 0 41163 0 10289 0 10600 0 14767 0 337937 0 0 CHARLES WILCOX III INTERIM DIV PRES (EFF 3/17) 0 255202 0 12445 0 9231 0 10600 0 10775 0 298253 0 0 DAVID GREEN DIRECTOR (EFF 5/17) 0 393160 0 111109 0 10288 0 16152 0 15409 0 546118 0 0 PART I PART I, LINE 1A THE SUBSIDIARIES OF THE INSTITUTE FOR TRANSFUSION MEDICINE DO NOT REIMBURSE FOR FIRST CLASS TRAVEL BUT SOMETIMES UPGRADES ARE MADE FOR BOARD MEMBERS AND SENIOR MANAGEMENT USING DISCOUNT OR FREQUENT FLIER COUPONS; EXECUTIVE/SOCIAL DUES ARE PAID FOR THE CEO AND CFO; AIRLINE AND EXECUTIVE CLUB DUES ARE PAID FOR SOME OF SENIOR MANAGEMENT. PART I, LINE 3 THE INSTITUTE FOR TRANSFUSION MEDICINE, THE PARENT COMPANY, ESTABLISHES THE COMPENSATION OF THE CEO USING THE SIX MEASURES DESCRIBED IN PART I, LINE 3. PART I, LINE 4A EFFECTIVE MARCH 1, 2017, THE INSTITUTE FOR TRANSFUSION MEDICINE ("ITXM"), THE CENTRAL PARENT ORGANIZATION OF THE ORGANIZATIONS INCLUDED IN THIS GROUP FORM 990, AMENDED ITS ARTICLES OF INCORPORATION AND BYLAWS SUCH THAT BLOOD SYSTEMS INC ("BSI") BECAME ITXM'S SOLE CORPORATE MEMBER. AS PART OF THE MARCH 1, 2017 BSI MEMBERSHIP EVENT, ITXM'S BOARD OF DIRECTORS WAS RECONSTITUTED. PRIOR TO MARCH 1, 2017, THE FORMER ITXM BOARD APPROVED A SEVERANCE OR CHANGE-OF-CONTROL PAYMENT DESCRIBED IN PART I, LINE 4A FOR ITXM'S FORMER CEO. THIS PAYMENT WAS MADE BEFORE MARCH 1, 2017, BUT AFTER DECEMBER 31, 2016. THEREFORE, ALTHOUGH THE PAYMENT WAS MADE DURING ITXM'S 2016 (FY 6.30.17) TAX YEAR, BECAUSE SUCH PAYMENT IS REPORTED ON THE FORMER ITXM CEO'S 2017 FORM W-2, IT IS NOT REFLECTED IN THE FORMER CEO'S COMPENSATION REPORTED IN PART VII OF THE FORM 990 OR IN PART II OF SCHEDULE J. IN COMPLIANCE WITH THE FORM 990 INSTRUCTIONS, THE FORMER CEO'S 2016 W-2 AND OTHER 2016 COMPENSATION IS REPORTED ON THIS RETURN. THE SEVERANCE OR CHANGE-OF-CONTROL PAYMENT INCLUDED IN THE FORMER ITXM CEO'S 2017 FORM W-2 WILL BE REFLECTED ON ITXM'S 2017 FORM 990. PART I, LINE 4B JAMES COVERT-TERMINATED 02/17 $176,974; MARK GIAQUINTO-TRANSFERRED TO BLOOD SCIENCE FOUNDATION 03/17 $64,903; DIANE MERKT-TERMINATED 04/17 $60,117; ANDREA CORTESE-HASSETT $56,454; LINDA HAHN RECEIVED A REQUIRED NON QUALIFIED PLAN DISTRIBUTION PAYMENT OF $28,018. PART II PART I, LINES 5 AND 6 AND PART II B(II) PERFORMANCE BASED BONUSES ARE PAID TO SENIOR AND MIDDLE MANAGEMENT ACCORDING TO CRITERIA WHICH IS ESTABLISHED AT THE BEGINNING OF THE YEAR BY THE COMPENSATION COMMITTEE OF THE BOARD. THE CRITERIA INCLUDES THE ORGANIZATION'S OVERALL OPERATING AND FINANCIAL RESULTS ALONG WITH ACTIVITY AND QUALITY METRICS. X OIL CHANGE VOUCHERS 1 51425 FMV X GIFT CARDS/CERTIFICATES 43 81792 FMV X OTHER 7 12215 FMV false true false PART III LINE 3 THE PROGRAM SERVICE ACCOMPLISHMENTS OF THE BLOOD SCIENCE FOUNDATION ("BSF") (EIN: 25-1562715) ARE NOT REPORTED ON LINE 4D THIS YEAR AS THIS ENTITY IS NO LONGER INCLUDED IN THE GROUP RETURN. EFFECTIVE MARCH 1, 2017, BSF AMENDED ITS ARTICLES OF INCORPORATION AND BYLAWS TO REMOVE THE INSTITUTE FOR TRANSFUSION MEDICINE ("ITXM") AS BSF'S SOLE CORPORATE MEMBER. AS A RESULT, ITXM, THE CENTRAL PARENT ORGANIZATION OF THE SUBSIDIARIES OF THE INSTITUTE FOR TRANSFUSION MEDICINE GROUP RULING ("THE GROUP RULING"), DOES NOT HAVE THE REQUISITE CONTROL OVER BSF FOR BSF TO BE INCLUDED IN THE GROUP RULING. FOR THE TAX YEAR ENDED JUNE 30, 2017, BSF FILED A SEPARATE FORM 990. PART VI, SECTION A, LINE 6 THE INSTITUTE FOR TRANSFUSION MEDICINE IS THE SOLE CORPORATE MEMBER OF EACH ORGANIZATION THAT IS INCLUDED IN THIS FORM 990. PART VI, SECTION A, LINES 7A & 7B THE INSTITUTE FOR TRANSFUSION MEDICINE, AS THE SOLE CORPORATE MEMBER OF EACH ORGANIZATION INCLUDED IN THE GROUP RETURN, HAS THE POWER TO CARRY OUT THE LISTED FUNCTIONS WITH RESPECT TO EACH ORGANIZATION INCLUDED IN THE GROUP RETURN: (A) OVERSEE AND MONITOR THE CONDUCT OF THE BUSINESS AND ACTIVITIES TO DETERMINE WHETHER THEY ARE PROPERLY MANAGED IN RELATION TO THE CHARITABLE, COMMUNITY SERVICE AND STRATEGIC MISSION AND GOALS OF THE CORPORATION AND IN COMPLIANCE WITH APPLICABLE LAWS, REGULATIONS AND BOARD-MANDATED POLICIES; (B) EXERT FINAL DECISION-MAKING AUTHORITY OVER CHOICES RELATING TO ORGANIZATIONAL STRUCTURE, STRATEGIC GOALS AND ECONOMIC OBJECTIVES, MAJOR OPERATING POLICIES AND SIGNIFICANT FINANCIAL ACCOUNTING PRINCIPLES AND PRACTICES; (C) SELECT, REGULARLY EVALUATE, FIX THE COMPENSATION OF AND (WHEN APPROPRIATE) REPLACE THE SENIOR EXECUTIVE OFFICERS AND THE MEMBERS OF THE BOARD; (D) SELECT EXTERNAL CERTIFIED PUBLIC ACCOUNTANTS TO CONDUCT AN ANNUAL EXAMINATION AND AUDIT OF THE CORPORATION'S FINANCIAL STATEMENTS; (E) SELECT CORPORATE LEGAL COUNSEL TO ADVISE THE BOARD IN PERFORMING ITS FUNCTIONS AND THE MEMBERS OF THE BOARD IN PERFORMING THEIR FIDUCIARY DUTIES; (F) REVIEW AND APPROVE MAJOR PLANS, COMMITMENTS AND INITIATIVES, INCLUDING ACQUISITIONS, DIVESTITURES AND CAPITAL EXPENDITURE PROGRAMS AND PROJECTS, PROPOSED BY THE SENIOR EXECUTIVE OFFICERS, ALL WITH DUE REGARD FOR POTENTIAL BENEFITS AND RISKS RELATIVE TO THE CORPORATION'S CHARITABLE, COMMUNITY SERVICE AND STRATEGIC MISSION AND GOALS; (G) PROVIDE ADVICE AND GUIDANCE TO THE SENIOR EXECUTIVE OFFICERS IN CONNECTION WITH THE BUSINESS AND ACTIVITIES AND ASSIST IN GAINING ACCESS TO KEY EXTERNAL RESOURCES FOR ADVANCEMENT OF THE CHARITABLE AND COMMUNITY SERVICE MISSION; AND (H) EXERCISE SUCH OTHER POWERS AS HAVE BEEN DELEGATED AND PERFORM SUCH OTHER FUNCTIONS AS ARE PRESCRIBED BY APPLICABLE LAWS AND REGULATIONS. PART VI, SECTION B, LINE 11 THE 990 IS COMPLETED BY MANAGEMENT AND IS REVIEWED BY AN EXTERNAL, INDEPENDENT ACCOUNTING FIRM. THE 990 HAS BEEN REVIEWED BY THE PARENT'S EXECUTIVE LEADERSHIP AND A COPY HAS BEEN SENT TO THE BOARD GOVERNING THE SUBSIDIARIES FOR THEIR REVIEW PRIOR TO FILING. PART VI, SECTION B, LINE 12C PRIOR TO MARCH 1, 2017, THE SUBSIDIARIES OF THE INSTITUTE FOR TRANSFUSION MEDICINE FOLLOWED ITXM'S CONFLICT OF INTEREST POLICY. UNDER THIS POLICY, ALL DIRECTORS, OFFICERS AND KEY EMPLOYEES WERE REQUIRED TO SUBMIT A FORM ANNUALLY DISCLOSING ANY ACTUAL OR POSSIBLE CONFLICTS OF INTEREST. THE FORMS WERE REVIEWED BY THE GOVERNANCE COMMITTEE WHICH THEN DETERMINED WHETHER A CONFILCT EXISTED. ANY PERSON DEEMED TO HAVE A CONFLICT DURING THE YEAR WAS PROHIBITED FROM PARTICIPATING IN DELIBERATIONS AND DECISIONS REGARDING CONFLICTED TRANSACTIONS. EFFECTIVE MARCH 1, 2017, THE RECONSTITUTED BOARDS OF THE SUBSIDIARIES ADOPTED A CONFLICT OF INTEREST POLICY THAT MIRRORED BSI'S POLICY. PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE OF THE INSTITUTE FOR TRANSFUSION MEDICINE BOARD OF DIRECTORS RETAINS AN INDEPENDENT, THIRD-PARTY COMPENSATION CONSULTANT TO ANNUALLY REVIEW AND ANALYZE THE MARKET COMPETITIVENESS, REASONABLENESS AND APPROPRIATENESS OF EXECUTIVE PAY AT ITXM AND ITS SUBSIDIARIES. THIS ANALYSIS INCLUDES THE CEO, EXECUTIVES REPORTING DIRECTLY TO THE CEO AND EMPLOYEES WHOSE BASE SALARIES EXCEED THE LOWEST PAID DIRECT REPORT TO THE CEO. AT THE REQUEST OF THE COMPENSATION COMMITTEE, THE COMPENSATION CONSULTANT CONDUCTS AN ANNUAL COMPETITIVE ANALYSIS THAT FOCUSES ON BASE PAY, SHORT-TERM INCENTIVE PAY AND LONG-TERM INCENTIVE PAY AND CONDUCTS A TOTAL COMPENSATION ANALYSIS INCLUSIVE OF INDIRECT COMPENSATION AND OTHER NON-CASH COMPENSATION ELEMENTS EVERY THREE TO FIVE YEARS DEPENDING ON REGULATORY, LEGISLATIVE AND EXTERNAL ACTIONS AND TRENDS. THE COMPETITIVE ANALYSES ARE CONDUCTED ACCORDING TO A BOARD-APPROVED EXECUTIVE COMPENSATION STRATEGY AND MARKET ANALYSIS METHODOLGY. PART VI, SECTION C LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. PART VII, SECTION A EFFECTIVE WITH THE BSI MERGER, THE BOARD OF DIRECTORS FOR CENTRAL BLOOD BANK, LIFESOURCE BLOOD SERVICES, VIRGINIA BLOOD SERVICES, ITXM CLINICAL SERVICES AND ITXM DIAGNOSTICS MIRROR THAT OF ITXM. AS SUCH, THE FOLLOWING ITXM BOARD MEMBERS AND OFFICERS ALSO SERVE AS BOARD MEMBERS AND OFFICERS FOR THESE ENTITIES: PATRICIA ABREGO-SANTUCCI SUNNY CHICO ROBERT COLE J. DANIEL CONNOR (THRU 5/17) MICHAEL JONES JOHN LEWIS RICHARD MCHUGH JAMES SCHRAITH PAUL SANDERS SUSAN BARNES BHAVI SHAH CHARLES WILCOX DAVID GREEN (EFF 5/17) PART XI, LINE 9 BLOOD SCIENCE FOUNDATION (NO LONGER PART OF GROUP RETURN) $ (98,619,532) FUND BALANCE TRANSFERS TO PARENT (1,786,564) TOTAL TO FORM 990, PART XI, LINE 9 $(100,406,096) BLOOD SCIENCE FOUNDATION 875 GREENTREE ROAD PARKWAY CENTER PITTSBURGH PA 15220 251562715 FUNDRAISING PA 501(c)(3) 12D ITXM true BLOOD SYSTEMS INC 6210 E OAK ST SCOTTSDALE AZ 85257 860098929 BLOOD BANK AZ 501(C)(3) 10 NA false CREATIVE TESTING SOLUTIONS 6210 EAST OAK STREET SCOTTSDALE AZ 85257 271120123 SAFETY TEST AZ 501(C)(3) 11 BSI true BLOOD BANK SAN BERNARDINORIVERSIDE FDN POBOX 1429 SAN BERNARDINO CA 92402 208911074 FUNDRAISING CA 501(C)(3) 12-TYPE I BBSBRC true GEISINGER BLOOD CTR PC5 875 GRNTREE RD PGHPA 15220 PITTSBURGH PA 15220 364718005 BLOOD BANK PA NA CANYON STATE INSURANCE COMPANY WEST BAY ROAD GRAND CAYMAN CJ 941084327 INVESTMENT CJ N/A FOREIGN BIOCARE INC 6210 E OAK ST SCOTTSDALE AZ 85257 813906720 PHARMA AZ N/A C CORP TRANSFUSION TECHNOLOGY INC 102 CHESTNUT RIDGE ROAD MONTVALE NJ 07645 223494865 INACTIVE NJ N/A C CORP false false false false false false false false false true false true true false false true true false false LIFESOURCE GEISINGER BLOOD CENTER L 3232696 FMV INSTITUTE FOR TRANSFUSION MEDICINE J 569849 FMV INSTITUTE FOR TRANSFUSION MEDICINE M 22276090 FMV INSTITUTE FOR TRANSFUSION MEDICINE P 2121564 FMV BLOOD SYSTEMS INC P 6514604 FMV BLOOD BANK OF SAN BERNARDINO & RIVERSIDE P 200836 FMV BERGEN COMMUNITY REGIONAL BLOOD CENTER INC P 99228 FMV BLOOD SYSTEMS INC Q 90552 FMV CREATIVE TESTING SOLUTIONS J 160995 FMV CREATIVE TESTING SOLUTIONS M 4401106 FMV BIOCARE INC P 1317589 FMV PART III EFFECTIVE JANUARY 31, 2017, THE BOARD OF DIRECTORS VOTED TO DISSOLVE GEISINGER BLOOD CENTER. CENTRAL BLOOD BANK 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251055312 INST LIFESOURCE 5 PARKWAY CENTER 875 GREENTREE RD pittsburgh PA 15220 363492969 INST ITXM CLINICAL SERVICES 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251839168 INST HEMOPHILIA CENTER OF WESTERN PA 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251562716 INST itxm diagnostics inc 5 PARKWAY CENTER 875 GREENTREE RD pittsburgh PA 15220 030497690 INST VIRGINIA BLOOD SERVICES 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 540959121 INST